160 filings
8-K
AUGX
Augmedix Inc
4 Jun 24
Augmedix Reiterates Second Quarter and Full Year 2024 Outlook
7:19pm
10-Q
2024 Q1
AUGX
Augmedix Inc
Quarterly report
13 May 24
4:15pm
8-K
AUGX
Augmedix Inc
13 May 24
Augmedix Delivers 40% Revenue Growth for First Quarter of 2024
4:09pm
10-K/A
2023 FY
AUGX
Augmedix Inc
Annual report (amended)
29 Apr 24
4:03pm
8-K
AUGX
Augmedix Inc
18 Apr 24
Entry into a Material Definitive Agreement
4:29pm
8-K
tsq leaey1wrg4
15 Apr 24
Entry into a Material Definitive Agreement
4:05pm
S-8
brzgj9u4jnhm0fjvmn
27 Mar 24
Registration of securities for employees
7:53pm
8-K
buzoqpmotwclj8
18 Mar 24
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
4:01pm
8-K
fj5o3ufp8
9 Jan 24
Entry into a Material Definitive Agreement
4:05pm
8-K
lrdliyquw
5 Jan 24
Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue
4:05pm
8-K
02jbkkb
29 Nov 23
Entry into a Material Definitive Agreement
5:11pm
8-K
k1ldl2euyjufu h6fvg0
21 Nov 23
Augmedix Announces Closing of Public Offering of Common Stock, Including Additional Investments from HCA Healthcare
12:00am
8-K
9el6b lnxt7lc3cl9hw
20 Nov 23
Augmedix Announces Proposed Public Offering of 5,500,000 Shares of Common Stock
4:05pm
424B5
osll 7thc1o
17 Nov 23
Prospectus supplement for primary offering
4:08pm
424B5
tktyi cawv9j82cqvr
15 Nov 23
Prospectus supplement for primary offering
5:14pm
8-K
f8u7k4
15 Nov 23
Other Events
4:08pm
8-K
3hdad
6 Nov 23
Augmedix Delivers 50% Revenue Growth and Expanded Gross Margins for Third Quarter of 2023
4:03pm
8-K
lzvcpp
6 Nov 23
Entry into a Material Definitive Agreement
4:03pm